Drugs / 18F-FCOB04
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07470710 | Mar → Dec 2026 expected | neurodegenerative disease | Peking Union Medical College Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 18F-FCOB04 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07470710 ↗ |
| Route | Intravenous | “Single intravenous administration of the investigational PET radiotracer 18F-FCOB04” NCT07470710 ↗ |